Fundraising FoxSonnet BioTherapeutics Holdings
Princeton, US · Delaware corporation
Find your way into Sonnet BioTherapeutics Holdings
Sign up to see every warm intro you have to Sonnet BioTherapeutics Holdings
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sonnet BioTherapeutics Holdings team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
PM
Pankaj MohanFounder
JK
John K. CiniExecutive
SD
Susan DexterExecutiveSusan Dexter is Chief Technology Officer at Sonnet BioTherapeutics, where she oversees development of biotherapeutic candidates for cancer treatment. She brings experience in biopharmaceutical drug development, manufacturing, process development, and CMC strategy, including management of multiple programs through preclinical studies and IND filings.
RK
Richard KennyExecutive
JC
Jay CrossExecutiveJay Cross held the Chief Financial Officer role at Sonnet BioTherapeutics, where he oversaw financial operations and investor relations, and later joined Senti Bio in the same capacity. He spent 20 years in healthcare finance, including roles as a managing director in healthcare investment banking at Chardan, as a portfolio manager at multiple asset management firms (SAC Capital, Citadel, and Balyasny), and as a biotechnology equity research analyst at Hambrecht & Quist and Goldman Sachs.
MP
Michael PruittChief Executive Officer
EL
Eric LedererChief Financial Officer
Board
AD
Albert DyrnessBoard director
NB
Nailesh BhattBoard director
DG
Donald GriffithBoard director
RR
Raghu RaoBoard director
LM
Lori McNeilBoard director
Reported raises · per SEC filings
Form D private placements$18M disclosed across 7 rounds · 2015–2024
▶$3.9MraisedDec 2024 · 4 investors · BiotechnologyRule 506(b)
▶$3.9MraisedDec 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John K. CiniExecutive Officer
- Albert DyrnessDirector
- Nailesh BhattDirector
- Pankaj MohanExecutive Officer, Director
- Donald GriffithDirector
- Susan DexterExecutive Officer
- Richard KennyExecutive Officer
- Raghu RaoDirector
- Jay CrossExecutive Officer
- Lori McNeilDirector
- Offering amount
- $3.9M
- Amount sold
- $3.9M
- Sales commissions
- $378.7K
- Placement agents
- Chardan Capital Markets, LLC
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedJul 2023 · 1 investors · BiotechnologyRule 506(b)
▶$2.3MraisedJul 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Pankaj MohanExecutive Officer, Director
- John K. CiniExecutive Officer
- Raghu RaoDirector
- Nailesh BhattDirector
- Susan DexterExecutive Officer
- Donald GriffithDirector
- Richard KennyExecutive Officer
- Albert DyrnessDirector
- Jay CrossExecutive Officer
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- Sales commissions
- $226.3K
- Placement agents
- Chardan Capital Markets, LLC
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.3MraisedAug 2022 · 5 investors · BiotechnologyRule 506(b)
▶$2.3MraisedAug 2022 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Albert DyrnessDirector
- Raghu RaoDirector
- Susan DexterExecutive Officer
- John K. CiniExecutive Officer
- Jay CrossExecutive Officer
- Pankaj MohanExecutive Officer, Director
- Donald GriffithDirector
- Nailesh BhattDirector
- Richard KennyExecutive Officer
- Offering amount
- $2.3M
- Amount sold
- $2.3M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedMay 2018 · 13 investors · RestaurantsRule 506(b)
▶$1.4MraisedMay 2018 · 13 investors · Restaurants
Rule 506(b)Officers, directors & promoters on the filing
- Russell J. PageDirector
- Keith J. JohnsonDirector
- Neil C. KieferDirector
- Larry S. SpitcaufskyExecutive Officer
- Mark RobersonExecutive Officer
- David P. OsbornDirector
- J. Eric WagonerDirector
- Eric LedererExecutive Officer
- Michael D. PruittExecutive Officer, Director, Promoter
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- Minimum investment
- $10.5K
- Sales commissions
- $36.8K
- Placement agents
- Oak Ridge Financial Services Group
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMay 2017 · 14 investors · RestaurantsRule 506(b)
▶$6MraisedMay 2017 · 14 investors · Restaurants
Rule 506(b)Officers, directors & promoters on the filing
- Keith J. JohnsonDirector
- Eric LedererExecutive Officer
- Russell PageDirector
- Michael D. PruittExecutive Officer, Director
- Mark RobersonExecutive Officer
- Gregory E. KrautDirector
- Rich AdamsExecutive Officer
- Neil C. KieferDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $50K
- Sales commissions
- $260.2K
- Placement agents
- T.R. Winston & Company LLC
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedMar 2015 · 1 investors · RestaurantsRule 506(b)
▶$1MraisedMar 2015 · 1 investors · Restaurants
Rule 506(b)Officers, directors & promoters on the filing
- Michael PruittExecutive Officer, Director
- Michael CarrollDirector
- Russell PageDirector
- Keith JohnsonDirector
- Paul MoskowitzDirector
- Eric LedererExecutive Officer
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $25K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedJan 2015 · 12 investors · RestaurantsRule 506(b)
▶$1.1MraisedJan 2015 · 12 investors · Restaurants
Rule 506(b)Officers, directors & promoters on the filing
- Paul MoskowitzDirector
- Michael PruittExecutive Officer, Director
- Michael CarrollDirector
- Keith JohnsonDirector
- Eric LedererExecutive Officer
- Russell PageDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- Minimum investment
- $25K
- Sales commissions
- $9K
- Placement agents
- Source Capital Group
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Sonnet BioTherapeutics Holdings?
- Sonnet BioTherapeutics Holdings was founded by Pankaj Mohan.
- How much funding has Sonnet BioTherapeutics Holdings raised?
- Sonnet BioTherapeutics Holdings has disclosed $18M raised across 7 rounds.
- Where is Sonnet BioTherapeutics Holdings headquartered?
- Sonnet BioTherapeutics Holdings is headquartered in Princeton, US.